Home›Compare›Invigor Medical vs SnagRx

Invigor Medical vs SnagRx: Which Is Better?

Head-to-head comparison of Invigor Medical and SnagRx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Invigor Medical scores higher overall in our independent evaluation (62/100 vs 54.8/100), leading on trust & safety, experience, product range, reputation. SnagRx comes out ahead on value. SnagRx has the lower entry price (from $69/mo vs $100/mo), so the better value depends on which treatment you need.

Invigor Medical (now Try Invigor) is a Washington-based peptide, hormone and sexual-health telehealth clinic with one of the broadest compounded menus in the category, priced toward the high end.

Visit Invigor Medical
55
SnagRx
Below Average

SnagRx is a 2026 compounded-GLP-1 storefront run by Modern Metabolic Medicine, Inc., which also operates Embody and RodeoMeds. It sells semaglutide from $69/mo and tirzepatide from $119/mo on 12-month prepay.

Visit SnagRx

Score Breakdown

DimensionInvigor MedicalSnagRx
Overall Score62/100 ✓54.8/100
Trust & Safety30%62/100 ✓50/100
Value25%55/10085/100 ✓
Experience20%58/100 ✓45/100
Product Range15%80/100 ✓40/100
Reputation10%60/100 ✓35/100

At a Glance

Founded20182026
HeadquartersKennewick, WAWilmington, DE
Publicly tradedNoNo
Treatment categories61
Treatments listed162
Starting price$100/mo$69/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryInvigor MedicalSnagRx
Weight Loss / GLP-1$110
Lipo-B12 Injections
$69–$99
Compounded Semaglutide

Invigor Medical

+Very broad compounded menu: GLP-1s, sermorelin, NAD+, glutathione, methylene blue, TRT, enclomiphene, Trimix, PT-141 and oxytocin
+Names its medical group (Dr Telx LLC) and pharmacy partners (GoGo Meds, Tailor Made, Strive, Belmar, Olympia)
+Eight-year operating history with a large Trustpilot base (~1,783 reviews, 4.4/5)
−Prices run high versus peers, e.g., NAD+ injections from $340/mo and GLP-1/GIP from $350/mo
−Recent Trustpilot reviews cite multi-week shipping delays, surprise charges and difficulty cancelling; 10% of all reviews are one-star
−Renewals must be cancelled 7+ days ahead, the first renewal can be charged early, and orders become non-refundable once in the practitioner queue
Read the full Invigor Medical review →

SnagRx

+Among the lowest compounded GLP-1 prices we track: semaglutide $69–99/mo and tirzepatide $119–149/mo, flat across doses, no membership fee
+Names four dispensing pharmacies and its prescriber network (OpenLoop Health)
+Consult, supplies and 1–2 day temperature-controlled shipping included
−Multi-month plans are non-refundable in whole and in part; reviewers say the $69/mo headline was not clear as a $828 upfront charge
−Parent company's shared BBB profile (SnagRx, Embody, RodeoMeds) is rated C with 72 complaints; the common ownership is not disclosed on the storefronts
−Claims 125,000+ customers but has only a handful of Trustpilot reviews (3.1/5), citing 19-day fulfillment delays
Read the full SnagRx review →

Invigor Medical vs SnagRx — FAQ

Is Invigor Medical better than SnagRx?

▾

Invigor Medical scores higher overall in our independent evaluation (62/100 vs 54.8/100), leading on trust & safety, experience, product range, reputation. SnagRx comes out ahead on value. SnagRx has the lower entry price (from $69/mo vs $100/mo), so the better value depends on which treatment you need.

Is Invigor Medical or SnagRx cheaper?

▾

SnagRx has the lower starting price (from $69/mo vs $100/mo for Invigor Medical). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Invigor Medical and SnagRx both offer?

▾

Both platforms treat Weight Loss / GLP-1. Invigor Medical covers 6 treatment categories total and SnagRx covers 1.

Still deciding?